EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Clinical status, biochemical profile and management of a single cohort of patients with arginase deficiency

Nandaki Keshavan iD, Michelle Wood, Lucy M Alderson, Mario Cortina-Borja, Rachel Skeath, Mel McSweeney, Marjorie Dixon, Maureen A Cleary, Emma Footitt, Spyros Batzios

JIMD Reports · 2022-03 · 63 (2) · 123-130

DOI: 10.1002/jmd2.12266 ↗

Kurz gefasst

Fallbericht in der Zeitschrift JIMD Reports, online erschienen am 30.12.2021. Verfasst von Nandaki Keshavan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatric Metabolic Medicine Great Ormond Street Hospital NHS Trust London UK. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Great Ormond Street Hospital Charity.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Arginase deficiency is a rare autosomal recessive urea cycle disorder (UCD) caused by mutations in the ARG1 gene encoding arginase that catalyses the hydrolysis of arginine to ornithine and urea. Patients have hyperargininaemia and progressive neurological impairment but generally suffer fewer metabolic decompensations compared to other UCDs. The objective is to describe the clinical features, biochemical profile, neuroradiological findings and experience of managing children with arginase deficiency. Twenty‐year retrospective review of patient medical records at a single metabolic centre was performed. Six patients from three unrelated families were identified. Mean age at first symptom was 3.3 (1.5–9.0) years, while mean age at diagnosis was 8.8 (0.16–15.92) years. Four patients developed spastic diplegia and two of six with spastic quadriplegia with classical features including hyperreflexia, clonus and toe walking. This resulted in gait abnormalities that have been monitored using the GAITRite system and required Achilles tendon release in five children. Generalised tonic‐clonic seizures and/or absences were present in three of six children and were controlled with anticonvulsants. All patients had moderate learning difficulties. Neuroimaging showed cerebral/cerebellar atrophy in four patients and basal ganglia abnormalities in two. Arginine levels were universally elevated throughout follow‐up despite protein restriction, essential amino acid supplementation and ammonia scavengers, and neurological outcome was generally poor. Two patients died following severe metabolic decompensation in adolescence. Children with arginase deficiency continue to present a management challenge of what appears to be an inexorable course of neurocognitive impairment. Further insight into disease mechanisms may provide insight into novel treatment strategies.

Schlagwörter

Stichwörter der Autor:innen

arginase deficiencyhyperammonaemiametabolic decompensationtrial end pointsurea cycle disorder

Autor:innen und Institutionen

  • Department of Paediatric Metabolic Medicine Great Ormond Street Hospital NHS Trust London UK.
  • UCL Great Ormond Street Hospital Institute of Child Health London UK.
  • Department of Physiotherapy Great Ormond Street Hospital NHS Trust London UK.
  • Population, Policy and Practice Research and Teaching Department UCL Great Ormond Street Hospital Institute of Child Health London UK.
  • Department of Dietetics Great Ormond Street Hospital NHS Trust London UK.

ORCID-Profile: Nandaki Keshavan

Förderung

  • Great Ormond Street Hospital Charity

Zitieren

APA

Keshavan, N., Wood, M., Alderson, L. M., Cortina-Borja, M., Skeath, R., McSweeney, M., Dixon, M., Cleary, M. A., Footitt, E., & Batzios, S. (2022). Clinical status, biochemical profile and management of a single cohort of patients with arginase deficiency. JIMD Reports, 63(2), 123-130. https://doi.org/10.1002/jmd2.12266

Vancouver

Keshavan N, Wood M, Alderson LM, Cortina-Borja M, Skeath R, McSweeney M, et al. Clinical status, biochemical profile and management of a single cohort of patients with arginase deficiency. JIMD Reports. 2022;63(2):123-130. doi:10.1002/jmd2.12266

BibTeX
@article{Keshavan2022,
  author = {Keshavan, Nandaki and Wood, Michelle and Alderson, Lucy M and Cortina-Borja, Mario and Skeath, Rachel and McSweeney, Mel and Dixon, Marjorie and Cleary, Maureen A and Footitt, Emma and Batzios, Spyros},
  title = {Clinical status, biochemical profile and management of a single cohort of patients with arginase deficiency},
  journal = {JIMD Reports},
  year = {2022},
  volume = {63},
  number = {2},
  pages = {123--130},
  doi = {10.1002/jmd2.12266}
}
Kostenlos starten →